SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the December 2025 quarter moved up 29.74% to Rs. 5288.00 millions as compared to Rs. 4076.00 millions during the corresponding quarter last year.A slender decline of -14.41% was recorded to Rs. 1069.00  millions from Rs. 1249.00 millions in the corresponding previous quarter.Operating Profit reported a sharp decline to 1756.00 millions from 1974.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 5288.00 4076.00 29.74 29858.00 29371.00 1.66 40945.00 35689.00 14.73
Other Income 553.00 1680.00 -67.08 2082.00 2592.00 -19.68 3213.00 1047.00 206.88
PBIDT 1756.00 1974.00 -11.04 14207.00 18423.00 -22.88 24656.00 17417.00 41.56
Interest 83.00 34.00 144.12 226.00 108.00 109.26 196.00 145.00 35.17
PBDT 1673.00 1940.00 -13.76 13981.00 18315.00 -23.66 24460.00 17272.00 41.62
Depreciation 421.00 437.00 -3.66 1440.00 1263.00 14.01 2200.00 1719.00 27.98
PBT 1252.00 1503.00 -16.70 12541.00 17052.00 -26.45 22260.00 15553.00 43.12
TAX 183.00 254.00 -27.95 1822.00 2829.00 -35.60 3756.00 2487.00 51.03
Deferred Tax -79.00 -25.00 216.00 -806.00 -252.00 219.84 -319.00 -361.00 -11.63
PAT 1069.00 1249.00 -14.41 10719.00 14223.00 -24.64 18504.00 13066.00 41.62
Equity 358.00 358.00 0.00 358.00 358.00 0.00 358.00 358.00 0.00
PBIDTM(%) 33.21 48.43 -31.43 47.58 62.73 -24.14 60.22 48.80 23.39

Natco Pharma Share Price

1118.95 31.25 (2.87%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×